News
The ABCVM wanted to certify cardiologists outside of ABIM, but the recent denial doesn’t mean their efforts have stopped.
There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.
CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...
The dynamic field of advanced heart failure, and helping these patients live comfortably, has inspired this fellow.
The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.
The drug was approved last year for patients with hypertension currently not controlled on other BP-lowering agents.
The transition from adolescence can bring decreased physical activity, a worse diet, and little focus on overall CV health.
Though ischemic outcomes numerically favored the Amulet, confirmation in future studies is needed, experts say.
For every 100,000 runners who complete the full 42.2 km distance, there will be one cardiac arrest, new data show.
VIENNA, Austria—Patients who require a pacemaker implant in the 30 days after TAVI have significantly greater risks of death up to a decade later, according to an analysis of the Swiss TAVI registry.
The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.
With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results